Stopped: Terminated due to end of funding. Enrollment sufficient to evaluate primary and secondary outcomes measures.
This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receiving preventive care, and constantly facing healthcare discrimination. Members of the LGBTQ community have historically smoked at higher rates than the general population and thus could benefit greatly from targeted efforts to improve lung cancer screening and smoking cessation implementation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community stakeholders who participate in the Aim 1 interviews/focus groups (Aim 1)
Timeframe: Up to 3 months
Number of LBGTQ community members who participate in the Aim 2 focus groups (Aim 2)
Timeframe: Up to 9 months
Acceptability of patient navigation and smoking cessation interventions (Aim 3)
Timeframe: Up to 12 months
Patient satisfaction with navigator throughout navigation and smoking cessation interventions (Aim 3)
Timeframe: Up to 12 months
Effectiveness of navigation visit(s): knowledge (Aim 3)
Timeframe: Up to 12 months
Effectiveness of navigation visit(s): smoking cessation (Aim 3)
Timeframe: Up to 12 months